Gen9
Gen9 is a privately held company based in Cambridge, Massachusetts, focused on advancing synthetic biology to enhance the production of DNA content. Established in 2009 by experts in the field, Gen9 has developed a next-generation gene synthesis technology that enables high-throughput, automated DNA construct production with improved cost efficiency and accuracy compared to traditional methods. The company's innovations aim to support various industries, including enzyme and chemical production, pharmaceuticals, and biofuels, by facilitating the constructive application of synthetic biology techniques to improve genes, pathways, genomes, and organisms.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.